6505--770_Pharmaceuticals_VA CMOP National Office_36C77026Q0060
ID: 36C77026Q0060Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/0a89ee33482f4c4ea2116537eecdafaf/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of various dosages of Duloxetine HCl capsules, intended for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. This presolicitation notice (36C77026Q0060) outlines a requirement for monthly deliveries over a three-month period, with specific quantities and packaging details for each item, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to strict delivery and packaging standards. Interested vendors must submit their quotes, including a signed SF1449, a price schedule in Excel format, and a state wholesale distributor license, by January 2, 2026, with an estimated award date of January 23, 2026. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-1976
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77026Q0060_1.docx
    This government solicitation, 36C77026Q0060, issued by the Department of Veterans Affairs, seeks proposals for pharmaceutical products, specifically Duloxetine HCL in various dosages and quantities, for multiple VA Consolidated Mail Outpatient Pharmacy (CMOP) locations. Key requirements include adherence to delivery terms (e.g., USPS shippable, obligation number referencing, coordinated deliveries, tracking information), strict bar coding standards (GS1-128 or HIBCC, encoding NDC, ANSI/ISO/IEC Quality Grade C or better), and therapeutic equivalence (FDA “A” rated products). The solicitation details procedures for drug recalls for both Federal Supply Schedule (FSS) and Open Market, requiring prompt notification to various VA offices. Quoters must provide specific 11-digit National Drug Codes (NDCs) for each product, commit to product availability and price, and meet other requirements such as minimum expiration dates (12 months), child-proof caps for certain package sizes, and proper packaging with detailed packing slips. Compliance with the Drug Supply Chain Security Act (DSCSA) is mandatory, requiring Transaction History, Information, and Statements. The document also incorporates standard Federal Acquisition Regulation (FAR) clauses concerning contract terms, conditions, and various socio-economic programs.
    36C77026Q0060.docx
    The Department of Veterans Affairs, National CMOP Contracting Office, has issued a presolicitation notice (36C77026Q0060) for miscellaneous pharmaceuticals, specifically various dosages of Duloxetine HCl, for delivery to multiple CMOP facilities. This unrestricted solicitation, with a NAICS code of 325412 (Pharmaceutical Preparation Manufacturing) and product service code 6505 (Drugs and Biologicals), is subject to World Trade Organization Government Procurement and Free Trade Agreements, favoring U.S.-made or designated country end products. Responses are due by January 2, 2026, at 9:00 AM CST, with an estimated award date of January 23, 2026. Vendors must provide a signed SF1449, a price schedule in Excel, a state wholesale distributor license verifying DSCSA compliance, and a completed Trade Agreements Certificate. Submissions must be sent via email to Michael.McAlhaney@va.gov.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The "TRADE AGREEMENTS CERTIFICATE (FEB 2021)" provision outlines certification requirements for offerors in federal government solicitations, particularly regarding the origin of end products. Offerors must certify that each end product is U.S.-made or from a designated country, as defined by the
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77026Q0060.xlsx
    This government Request for Quote (RFQ) 36C77026Q0060, issued by the VA, seeks bids for monthly deliveries of Duloxetine HCl capsules in various dosages and quantities for three consecutive months. Quotes are due by January 2, 2026, with an estimated award date of January 23, 2026, and an estimated delivery date of February 6, 2026 (10 days ARO). Bidders must email quotes to Michael.McAlhaney@va.gov and comply with the Drug Supply Chain Security Act (DSCSA) by providing a state wholesale distributor license. Transaction history, information, and statements (TH, TI, TS) are preferred in EDI, EPCIS, or ASN formats and can be emailed to specific VA CMOP Procurement/Logistics groups. Deliveries are designated for multiple VA CMOP locations across the US. Required documents include a signed SF1449, a price schedule in Excel, the state wholesale distributor license, and a completed 52.225-6 Trade Agreements Certificate.
    Lifecycle
    Title
    Type
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77026Q0060
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    Metaxalone Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for Metaxalone Tablets, specifically 800 MG tablets available in 100-count and 500-count bottles. This procurement aims to secure a reliable supply of this pharmaceutical product, which is essential for various medical applications within military healthcare. Interested vendors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) between November 7 and December 7, 2025, by 3:00 PM EST, and are required to adhere to specific contract terms, including a subcontracting plan for large businesses and compliance with various federal regulations. For further inquiries, potential offerors can contact Jeremy Brown at jeremy.brown@dla.mil or Jason Wray at Jason.wray@dla.mil.